Payment overview · 2025
General Payments
$123.50
1 reported records · 1 companies
Healthcare provider profile · identity verified
Kazem Hak, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · FLINT, MI · NPI 1083688725
Verified facts
What the public records show
CMS Open Payments records show Kazem Hak, M.D. received $123.50 in general payments during 2025 across 1 reported records.
GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 110 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $123.50 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $123.50 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUCALA Normalized: nucala |
Biological | GlaxoSmithKline, LLC. | $123.50 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
110 | 30 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 960 | 262 |
| Levothyroxine Sodium | Levothyroxine Sodium | 754 | 191 |
| Alprazolam | Alprazolam | 647 | 109 |
| Losartan Potassium | Losartan Potassium | 589 | 152 |
| Omeprazole | Omeprazole | 588 | 152 |
| Lisinopril | Lisinopril | 472 | 128 |
| Amlodipine Besylate | Amlodipine Besylate | 458 | 127 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 402 | 108 |
| Tamsulosin Hcl | Tamsulosin Hcl | 400 | 110 |
| Metformin Hcl | Metformin Hcl | 374 | 97 |
| Metoprolol Succinate | Metoprolol Succinate | 336 | 89 |
| Duloxetine Hcl | Duloxetine Hcl | 323 | 81 |
| Gabapentin | Gabapentin | 294 | 66 |
| Eliquis | Apixaban | 281 | 63 |
| Simvastatin | Simvastatin | 280 | 70 |
| Trazodone Hcl | Trazodone Hcl | 273 | 66 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 260 | 54 |
| Metoprolol Tartrate | Metoprolol Tartrate | 251 | 64 |
| Sertraline Hcl | Sertraline Hcl | 248 | 66 |
| Furosemide | Furosemide | 241 | 66 |
| Potassium Chloride | Potassium Chloride | 211 | 62 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 207 | 56 |
| Clopidogrel | Clopidogrel Bisulfate | 193 | 57 |
| Carvedilol | Carvedilol | 190 | 50 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 181 | 32 |
| Tramadol Hcl | Tramadol Hcl | 179 | 41 |
| Meloxicam | Meloxicam | 175 | 56 |
| Finasteride | Finasteride | 173 | 45 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 165 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 150 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 149 | 45 |
| Bupropion Xl | Bupropion Hcl | 146 | 34 |
| Mounjaro | Tirzepatide | 135 | 20 |
| Montelukast Sodium | Montelukast Sodium | 129 | 36 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 127 | 31 |
| Allopurinol | Allopurinol | 123 | 28 |
| Atenolol | Atenolol | 119 | 30 |
| Rybelsus | Semaglutide | 119 | 27 |
| Buspirone Hcl | Buspirone Hcl | 118 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 113 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 112 | 28 |
| Fluticasone Propionate | Fluticasone Propionate | 111 | 51 |
| Alendronate Sodium | Alendronate Sodium | 110 | 30 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 110 | 30 |
| Nifedipine Er | Nifedipine | 105 | 27 |
| Temazepam | Temazepam | 105 | 19 |
| Ozempic | Semaglutide | 103 | 18 |
| Xarelto | Rivaroxaban | 103 | 25 |
| Glimepiride | Glimepiride | 101 | 28 |
| Celecoxib | Celecoxib | 100 | 27 |
| Jardiance | Empagliflozin | 100 | 24 |
| Methylprednisolone | Methylprednisolone | 100 | 84 |
| Pregabalin | Pregabalin | 99 | 24 |
| Zolpidem Tartrate | Zolpidem Tartrate | 98 | 22 |
| Clonazepam | Clonazepam | 88 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 86 | 22 |
| Quetiapine Fumarate | Quetiapine Fumarate | 85 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 84 | 61 |
| Ibuprofen | Ibuprofen | 83 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 83 | 26 |
| Hydrochlorothiazide | Hydrochlorothiazide | 78 | 22 |
| Warfarin Sodium | Warfarin Sodium | 78 | 14 |
| Azithromycin | Azithromycin | 76 | 68 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 74 | 25 |
| Donepezil Hcl | Donepezil Hcl | 74 | 20 |
| Diazepam | Diazepam | 72 | 13 |
| Memantine Hcl | Memantine Hcl | 71 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 71 | 16 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 69 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 67 | 30 |
| Linzess | Linaclotide | 67 | 17 |
| Nitroglycerin | Nitroglycerin | 67 | 36 |
| Propranolol Hcl Er | Propranolol Hcl | 66 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 65 | 22 |
| Dicyclomine Hcl | Dicyclomine Hcl | 64 | 18 |
| Entresto | Sacubitril/Valsartan | 64 | 12 |
| Icosapent Ethyl | Icosapent Ethyl | 64 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 63 | 19 |
| Diclofenac Sodium Er | Diclofenac Sodium | 61 | 19 |
| Ezetimibe | Ezetimibe | 61 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 61 | 21 |
| Ramipril | Ramipril | 61 | 16 |
| Telmisartan | Telmisartan | 61 | 17 |
| Eszopiclone | Eszopiclone | 59 | suppressed |
| Lorazepam | Lorazepam | 56 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 56 | 13 |
| Baclofen | Baclofen | 55 | 12 |
| Clonidine Hcl | Clonidine Hcl | 54 | 17 |
| Etodolac | Etodolac | 54 | 15 |
| Prednisone | Prednisone | 54 | 29 |
| Synthroid | Levothyroxine Sodium | 53 | 16 |
| Spironolactone | Spironolactone | 52 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 50 | 21 |
| Bumetanide | Bumetanide | 48 | 13 |
| Famotidine | Famotidine | 48 | 12 |
| Trulicity | Dulaglutide | 46 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 45 | 22 |
| Primidone | Primidone | 44 | suppressed |
| Buprenorphine | Buprenorphine | 43 | suppressed |
| Estradiol | Estradiol | 43 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 43 | 11 |
| Ondansetron Odt | Ondansetron | 42 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 42 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 41 | 11 |
| Mirtazapine | Mirtazapine | 41 | suppressed |
| Novolog Flexpen | Insulin Aspart | 41 | suppressed |
| Rexulti | Brexpiprazole | 41 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 40 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | 12 |
| Januvia | Sitagliptin Phosphate | 38 | 11 |
| Raloxifene Hcl | Raloxifene Hcl | 38 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 38 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 37 | suppressed |
| Mirabegron Er | Mirabegron | 36 | 13 |
| Naproxen | Naproxen | 36 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 35 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 35 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 35 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 34 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 33 | 16 |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Lansoprazole | Lansoprazole | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Acyclovir | Acyclovir | 30 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 30 | 25 |
| Paxlovid | Nirmatrelvir/Ritonavir | 30 | 30 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 29 | 24 |
| Fluconazole | Fluconazole | 29 | 22 |
| Methocarbamol | Methocarbamol | 29 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 29 | 15 |
| Armodafinil | Armodafinil | 28 | suppressed |
| Myrbetriq | Mirabegron | 28 | 12 |
| Topiramate | Topiramate | 28 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 28 | suppressed |
| Levofloxacin | Levofloxacin | 27 | 26 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 27 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 26 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 26 | suppressed |
| Cephalexin | Cephalexin | 26 | 20 |
| Nortriptyline Hcl | Nortriptyline Hcl | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 19 |
| Valsartan | Valsartan | 25 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 20 |
| Testosterone | Testosterone | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Amoxicillin | Amoxicillin | 23 | 16 |
| Doxepin Hcl | Doxepin Hcl | 23 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 22 | suppressed |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Methadone Hcl | Methadone Hcl | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 19 |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Digoxin | Digoxin | 20 | suppressed |
| Humulin R U-500 | Insulin Regular, Human | 20 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 20 | 14 |
| Ventolin Hfa | Albuterol Sulfate | 20 | 14 |
| Clonidine | Clonidine | 19 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 19 | suppressed |
| Sotalol | Sotalol Hcl | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 18 | suppressed |
| Repatha Sureclick | Evolocumab | 18 | suppressed |
| Savella | Milnacipran Hcl | 18 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Clotrimazole | Clotrimazole | 17 | 12 |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Calcitriol | Calcitriol | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 16 | suppressed |
| Fentanyl | Fentanyl | 16 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 16 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 15 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 14 | suppressed |
| Creon | Lipase/Protease/Amylase | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 12 |
| Humalog Kwikpen U-200 | Insulin Lispro | 14 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 13 | suppressed |
| Butalb-Acetaminoph-Caff-Codein | Butalbit/Acetamin/Caff/Codeine | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | 11 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Triazolam | Triazolam | 13 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Repatha Syringe | Evolocumab | 12 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 12 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Nexium | Esomeprazole Magnesium | 11 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $123.50 · 1 records | GlaxoSmithKline, LLC. | NUCALA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error